Improvement of Huntington's disease with olanzapine and valproate.

被引：62
|
作者：
Grove, VE [1 ]
Quintanilla, J [1 ]
DeVaney, GT [1 ]
机构：
[1] Kerrville State Hosp, Kerrville, TX 78029 USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2000年 / 343卷 / 13期
关键词：
D O I：
10.1056/NEJM200009283431316
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：973 / 974
页数：2
相关论文
共 50 条
  • [1] Olanzapine in Huntington's disease
    Paleacu, D
    Anca, M
    Giladi, N
    ACTA NEUROLOGICA SCANDINAVICA, 2002, 105 (06): : 441 - 444
  • [2] Olanzapine and Huntington's disease
    Bogelman, G
    Hirschmann, S
    Modai, I
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2001, 21 (02) : 245 - 246
  • [3] Olanzapine in Huntington's disease
    Paleacu, D
    Anca, M
    Giladi, N
    NEUROLOGY, 2000, 54 (07) : A421 - A421
  • [4] Valproate in Huntington's disease: Dose dependent improvement of myocloniform hyperkinesia
    Saft, C
    Lauter, T
    Kraus, PH
    Przuntek, H
    Andrich, JE
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2005, 76
  • [5] Dose dependent improvement of myocloniform hyperkinesias in Huntington's Disease with valproate
    Saft, C
    Andrich, J
    Lauter, T
    Kraus, P
    Przuntek, H
    Andrich, JE
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2005, 238 : S328 - S328
  • [6] Riluzole and olanzapine in Huntington's disease
    Bonelli, RM
    Niederwieser, G
    Diez, J
    Költringer, P
    EUROPEAN JOURNAL OF NEUROLOGY, 2002, 9 (02) : 183 - 184
  • [7] Quality of life improvement in patients treated with lamotrigine compared with valproate.
    Bryant-Comstock, L
    Kane, K
    Moorat, A
    EPILEPSIA, 1999, 40 : 98 - 99
  • [8] The effect of olanzapine on cognition in Huntington's disease
    Schwab, L.
    Mason, S.
    Barker, R.
    MOVEMENT DISORDERS, 2015, 30 : S538 - S538
  • [9] Olanzapine for Huntington's disease: An open label study
    Bonelli, RM
    Mahnert, FA
    Niederwieser, G
    CLINICAL NEUROPHARMACOLOGY, 2002, 25 (05) : 263 - 265
  • [10] Olanzapine for Huntington's disease: An open label study
    Bonelli, RM
    Hofmann, P
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S367 - S367
12345